(NaturalHealth365)  In 2023, it’s projected that about 2.0 million individuals in the United States will receive a cancer diagnosis.  Given the limited efficacy and significant side effects associated with traditional chemotherapy and radiation therapies, there’s a growing desire among researchers to explore alternative approaches.  Natural substances, such as Boswellia, have come under the spotlight due to their potential therapeutic benefits against cancer.

While the mainstream pharmaceutical sector might downplay its significance, emerging scientific research suggests that Boswellia, an age-old herbal remedy, could play a pivotal role.  In fact, recent studies indicate that Boswellia might not only inhibit the spread of cancer but could also serve as a preventive measure against its onset.

Boswellia brings new hope in the battle against inflammation and cancer

Boswellia, a natural substance used for thousands of years in herbal and Ayurvedic healing systems, is derived from the resin produced by Boswellia serrata, a tree indigenous to Asia, the Middle East, and Africa.  By the way, Boswellia is also known as frankincense – one of the gifts reportedly offered to the Christ child at birth.

Boswellia, a potent anti-inflammatory, has traditionally been used to relieve arthritis, ulcers, and gastrointestinal conditions.

Now, modern researchers are intrigued by Boswellia’s ability to combat inflammation – and its unique method of action, which completely differs from the mechanisms of conventional pharmaceutical medications.

NSAIDs and other anti-inflammatory drugs

Western medicine’s answer to excessive inflammation has been to develop NSAIDs – nonsteroidal anti-inflammatory medications – that block the production of pro-inflammatory enzymes, including a substance called cyclooxygenase, or COX-2.  Unfortunately, pharmaceutical COX-2 inhibitors also block the production of COX-1 – an enzyme essential to a healthy stomach lining – thereby triggering stomach irritation and bleeding, peptic ulcers, and kidney problems.

It was an attempt to solve this problem that led to the development of “selective” COX-2 inhibitors, which were designed to not interfere with the production of COX-1.  However, these selective inhibitors carried the potential for serious cardiac side effects, and some – such as Vioxx – were even taken off the market for this reason.

Don’t take these drug warnings lightly.  For example, if you remember, Vioxx was clearly linked to thousands of (preventable) deaths.  And the point is: there are much safer solutions for many of the health problems we face today.

Boswellia’s unique method of action targets inflammation and cancer – safely

Boswellia works dramatically differently, blocking a pro-inflammatory enzyme – 5-lipoxygenase, or 5-LOX – that triggers the production of pro-inflammatory leukotrienes and contributes to the development of cancer, arthritis, atherosclerosis, and asthma.

Boswellia not only suppresses 5-LOX but also inhibits the activity of human leukocyte elastase, or HLE, which is associated with respiratory conditions such as emphysema, cystic fibrosis, and chronic bronchitis.  So far, researchers have found no substance other than Boswellia that is capable of inhibiting both HLE and 5-LOX.

You may be shocked at what the scientific research reveals

In a laboratory cell study published in Molecular Pharmacology, researchers found that Boswellia extract worked better than the standard chemotherapy drugs camptothecin, amsacrine, and etoposide to inhibit the enzymes that promote cancer growth.

A study conducted at the Cleveland Clinic and published in Planta Medica showed that a Boswellia extract was effective against meningioma cells – which cause tumors of the brain’s covering.  Boswellia also helps to kill human prostate cancer cells, leukemia cells and brain cancer cells.

Plus, in a 2006 study published in Antioxidants and Redox Signaling, researchers found that Boswellia alters the expression of tumor necrosis factor-alpha – which, in excessive amounts, can produce biochemicals that promote the growth of tumor cells, along with cell adhesion related to the spread of cancer.

And, finally, Boswellia helps to combat melanoma – the most lethal form of skin cancer – by interfering with the ability of melanoma cells to metastasize.

Effects of an advanced Boswellia extract

The most important constituent of Boswellia is a triterpene known as AKBA or acetyl-11-keto-beta-boswellic acid.  AKBA binds directly to 5-LOX and can also reawaken “sleeping” genes that protect against cancer growth through DNA demethylation.

In other words, AKBA can inhibit cancer cell proliferation, reduce cancer cell viability, and decrease the survival of tumor-producing clonogenic cells.

So it’s not surprising that a Boswellia extract rich in AKBA – commercially available under the name 5-Loxin – shows particular promise in reducing the inflammation that lies at the root of cancer.  One study confirmed that 5-Loxin produced a 55 percent decrease in inflammation equal to that of prednisone – without the dangerous side effects.

How can I use Boswellia?

Boswellia, usually standardized to contain between 37.5 and 65 percent boswellic acid, is available in pill, resin, and cream form.  An herbalist may recommend amounts of up to 1,800 mg – two to three times a day.

The usual amount of the 5-Loxin form of Boswellia extract can range from 100 to 250 mg – once daily.

Naturally, you will want to consult with a trusted herbalist or holistic healthcare provider to determine the right amount for you.  A note of caution: if you are pregnant, don’t take boswellia; it can stimulate blood flow in the uterus and induce a miscarriage.

As a traditional remedy, Boswellia has undoubtedly been valued for its ability to reduce inflammation and joint pain.  Now (hopefully), with the help of some modern tweaking, this beneficial substance is ready to take its place as a cutting-edge natural solution in the fight against cancer.

Sources for this article include:

Cancer.gov
NIH.gov
LifeExtension.com
NIH.gov
NIH.gov
NIH.gov